The Source Blog
Recent Action in Pharmaceuticals
SB1030 – Oklahoma
Introduced: 2025 Status: In Process
This bill establishes the 340B Drug Pricing Nondiscrimination Act, which aims to protect entities participating in the federal 340B drug pricing program from discriminatory practices by health insurers, pharmacy benefits managers (PBMs), manufacturers, and distributors. […]
SB533 – Oregon
Introduced: 2025 Status: In Process
This bill addresses restrictions on drug manufacturers’ interactions with 340B covered entities, which are healthcare organizations that qualify for discounted drug pricing under a federal program. Specifically, the bill prohibits manufacturers from directly or indirectly […]
S0342 – South Carolina
Introduced: 2025 Status: In Process
This bill introduces several significant changes to pharmacy services regulation in South Carolina, focusing primarily on Pharmacy Benefits Managers (PBMs) and Medicaid pharmacy services. The bill defines a “low-volume pharmacy” as one dispensing fewer than […]
HB1119 – Mississippi
Introduced: 2025 Status:
This bill renames the “Pharmacy Benefit Prompt Pay Act” to the “Representative Andy Stepp Pharmacy Benefit Prompt Pay Act” and introduces comprehensive reforms to regulate pharmacy benefit managers (PBMs) in Mississippi. The bill defines key […]
HB1123 – Mississippi
Introduced: 2025 Status: In Process
This bill establishes comprehensive regulations for pharmacy benefit managers (PBMs) and pharmacy services administrative organizations (PSAOs) in Mississippi, aiming to increase transparency and prevent unfair practices in prescription drug pricing. The bill prohibits “spread pricing,” […]
HB1124 – Mississippi
Introduced: 2025 Status:
This bill requires pharmacy benefit managers (PBMs) to disclose detailed financial information and contract details, enhancing transparency in prescription drug pricing. Specifically, PBMs must disclose 100% of all rebates and payments received from pharmaceutical manufacturers […]
HB1584 – North Dakota
Introduced: 2025 Status: In Process
This bill proposes comprehensive reforms to regulate pharmacy benefits managers (PBMs) in North Dakota by establishing new licensing requirements, prohibiting certain business practices, and creating enforcement mechanisms. The legislation requires PBMs to obtain an annual […]
Previous | Next | See all Legislation Records
Introduced: 2025 Status: In Process
This bill establishes the 340B Drug Pricing Nondiscrimination Act, which aims to protect entities participating in the federal 340B drug pricing program from discriminatory practices by health insurers, pharmacy benefits managers (PBMs), manufacturers, and distributors. […]
SB533 – Oregon
Introduced: 2025 Status: In Process
This bill addresses restrictions on drug manufacturers’ interactions with 340B covered entities, which are healthcare organizations that qualify for discounted drug pricing under a federal program. Specifically, the bill prohibits manufacturers from directly or indirectly […]
S0342 – South Carolina
Introduced: 2025 Status: In Process
This bill introduces several significant changes to pharmacy services regulation in South Carolina, focusing primarily on Pharmacy Benefits Managers (PBMs) and Medicaid pharmacy services. The bill defines a “low-volume pharmacy” as one dispensing fewer than […]
HB1119 – Mississippi
Introduced: 2025 Status:
This bill renames the “Pharmacy Benefit Prompt Pay Act” to the “Representative Andy Stepp Pharmacy Benefit Prompt Pay Act” and introduces comprehensive reforms to regulate pharmacy benefit managers (PBMs) in Mississippi. The bill defines key […]
HB1123 – Mississippi
Introduced: 2025 Status: In Process
This bill establishes comprehensive regulations for pharmacy benefit managers (PBMs) and pharmacy services administrative organizations (PSAOs) in Mississippi, aiming to increase transparency and prevent unfair practices in prescription drug pricing. The bill prohibits “spread pricing,” […]
HB1124 – Mississippi
Introduced: 2025 Status:
This bill requires pharmacy benefit managers (PBMs) to disclose detailed financial information and contract details, enhancing transparency in prescription drug pricing. Specifically, PBMs must disclose 100% of all rebates and payments received from pharmaceutical manufacturers […]
HB1584 – North Dakota
Introduced: 2025 Status: In Process
This bill proposes comprehensive reforms to regulate pharmacy benefits managers (PBMs) in North Dakota by establishing new licensing requirements, prohibiting certain business practices, and creating enforcement mechanisms. The legislation requires PBMs to obtain an annual […]
Previous | Next | See all Legislation Records
Merck & Co., Inc. v. Becerra, et al. – Federal
District Court: District of Columbia Status: Pending
A complaint filed by Merck, a multinational pharmaceutical company, alleges that the drug price negotiation process detailed in the Inflation Reduction Act (IRA) violates the […]
FTC v. Amgen Inc. & Horizon Therapeutics Plc. – Federal
District Court: Northern District of Illinois, Eastern Division Status: Pending
The FTC filed a lawsuit requesting a temporary restraining order and preliminary injunction to block Amgen Inc. from acquiring Horizon Therapeutics. Amgen agreed to purchase […]
PhRMA v. Stolfi – Oregon
District Court: District Court of Oregon Status: Decided
PhRMA is challenging Oregon’s drug price transparency laws HB 4005, 2018 (Disclosure Law) and HB 2658, 2019 (Advance Notification Law) alleging that the laws are […]
Pharmaceutical Care Management Association (PCMA) v. Mulready – Oklahoma
District Court: District Court of Western District of Oklahoma Status: Decided
The 2019 Oklahoma law, Patient’s Right to Pharmacy Choice Act, targets PBM conflict of interest by prohibiting higher reimbursement rates for PBM-owned pharmacies and bans […]
State of Ohio v. OptumRx – Ohio
District Court: Ohio Court of Common Pleas (Franklin County) Status: Pending
On March 15, 2019, Ohio’s attorney general Dave Yost sued OptumRx in Ohio state court, claiming that between 2015 and 2018, the PBM failed to pass […]
Pharm. Care Mgmt. Ass’n v. Gerhart – Iowa
District Court: Southern District of Iowa Status: Decided
Trade association representing pharmacy benefits managers (PBM) brought action against State of Iowa, seeking declaration that statute that regulated how PBMs established generic drug pricing […]
Pharm. Care Mgmt. Ass’n v. Tufte – North Dakota
District Court: District of North Dakota Status: Pending
Trade association representing pharmacy benefit managers (PBMs) brought action against North Dakota state officials in their official capacities, alleging that Employee Retirement Income Security Act […]
Next | See all Litigation Records
District Court: District of Columbia Status: Pending
A complaint filed by Merck, a multinational pharmaceutical company, alleges that the drug price negotiation process detailed in the Inflation Reduction Act (IRA) violates the […]
FTC v. Amgen Inc. & Horizon Therapeutics Plc. – Federal
District Court: Northern District of Illinois, Eastern Division Status: Pending
The FTC filed a lawsuit requesting a temporary restraining order and preliminary injunction to block Amgen Inc. from acquiring Horizon Therapeutics. Amgen agreed to purchase […]
PhRMA v. Stolfi – Oregon
District Court: District Court of Oregon Status: Decided
PhRMA is challenging Oregon’s drug price transparency laws HB 4005, 2018 (Disclosure Law) and HB 2658, 2019 (Advance Notification Law) alleging that the laws are […]
Pharmaceutical Care Management Association (PCMA) v. Mulready – Oklahoma
District Court: District Court of Western District of Oklahoma Status: Decided
The 2019 Oklahoma law, Patient’s Right to Pharmacy Choice Act, targets PBM conflict of interest by prohibiting higher reimbursement rates for PBM-owned pharmacies and bans […]
State of Ohio v. OptumRx – Ohio
District Court: Ohio Court of Common Pleas (Franklin County) Status: Pending
On March 15, 2019, Ohio’s attorney general Dave Yost sued OptumRx in Ohio state court, claiming that between 2015 and 2018, the PBM failed to pass […]
Pharm. Care Mgmt. Ass’n v. Gerhart – Iowa
District Court: Southern District of Iowa Status: Decided
Trade association representing pharmacy benefits managers (PBM) brought action against State of Iowa, seeking declaration that statute that regulated how PBMs established generic drug pricing […]
Pharm. Care Mgmt. Ass’n v. Tufte – North Dakota
District Court: District of North Dakota Status: Pending
Trade association representing pharmacy benefit managers (PBMs) brought action against North Dakota state officials in their official capacities, alleging that Employee Retirement Income Security Act […]
Next | See all Litigation Records
News & Opinions
Articles & Reports
JAMA Network
February 28, 2025
Health Affairs Forefront January 14, 2025
Value in Health Journal December 1, 2024
Health Affairs December 1, 2024
Health Affairs Forefront January 14, 2025
Value in Health Journal December 1, 2024
Health Affairs December 1, 2024
Trends in Pharmaceuticals
2019 Pharmaceutical Legislation
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2019 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Price Transparency
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Rate Setting
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Price Gouging
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Drug Importation
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Pharmacy Gag Clause Regulation
Gag clause regulation includes laws that allow pharmacists to disclose costs to insured patients and those that prohibit pharmacists from collecting more in cost-sharing from the insured patient than the cash price. See The Source’s Spotlight on 2018 State Drug Legislation Part 3 and 2018 legislation chart for more information.
-
Key:
- Enacted
- Considered
- No Legislative Session
PBM Regulation
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Pharma Other
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session